Lidocaine and Seizure Length in ECT

Out on PubMed, from authors in Spain, is this study:

Does Lidocaine Shorten Seizure Duration in Electroconvulsive Therapy?
López-Ilundain J, Prados AB, Enriquez ÁSR, Enguita-Germán M, Rosquil EU, Gil JL, Fábrega AM, Martinez de Zabarte Moraza E, Maughan AR, Yoldi-Murillo J.Pharmacopsychiatry. 2023 Aug 29. doi: 10.1055/a-2114-4327. Online ahead of print.PMID: 37643731


The abstract is copied below:
Background: Electroconvulsive therapy (ECT) is an effective short-term treatment for schizophrenia and depression, amongst other disorders. Lidocaine is typically added to reduce pain from intravenous propofol injection. However, depending on the dose used in the ECT setting, it can shorten seizure duration. The aim of this study was to investigate the effect of lidocaine dose on seizure duration.

Methods: This retrospective, naturalistic cohort study included 169 patients treated with ECT. We examined 4714 ECT sessions with propofol or propofol plus lidocaine. Ictal quality was manually rated by visual inspection. The main outcome of this study was the relation of lidocaine with seizure duration after controlling for socio-demographic, ECT, and other anesthetic variables.

Results: There was a significant negative association between lidocaine usage and seizure duration. Multivariate analyses showed that seizure duration was shortened by an average of 3.21 s in sessions with lidocaine. Moreover, in this subgroup, there was a significant negative dose-dependent association between lidocaine dose and seizure length. Complementarily, a significant positive association between preictal BIS and seizure length was found in the subgroup of sessions where preictal was used.

Conclusions: We provide additional evidence highlighting the importance of caution regarding lidocaine dosing due to the effect on seizure length in the ECT setting. It is advisable for clinicians to exercise caution when administering lidocaine regarding its dosing and seizure length in ECT settings. Future investigation is needed to assess causal relationships by studying certain vulnerable groups or employing other charge calculation techniques, such as the titration method.

The paper is here.
And from the text:



Well here is some quantification of the obvious. We have known that lidocaine shortens seizure since the work of Cronholm and Ottosson in the 1960s (not mentioned in this paper). But does it matter? And why were so many patients given lidocaine to reduce the stinging of propofol? This should be uncommon, not standard practice. And the authors' repeated praise of the BIS monitor seems exaggerated. Note that the seizures in this patient cohort were very short, but there are no depression outcome data to let us know if this mattered. These results may be of interest to students of the ECT anesthesia literature, but their clinical relevance is questionable.

Comments

Popular posts from this blog

ECT plus Antidepressants: a Review

Clinical Phenotype of Behavioral-Variant Frontotemporal Dementia Reversed by ECT: A Case Report

Early Use of the Name "ECT"- Sacklers in 1949